Log in
Enquire now
‌

US Patent 11908130 Apparatuses and methods for digital pathology

Patent 11908130 was granted and assigned to Protein Metrics Inc. on February, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
‌
Protein Metrics Inc.
0
Current Assignee
‌
Protein Metrics Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
119081300
Patent Inventor Names
Marshall Bern0
Eric Carlson0
Michael J. Natan0
Date of Patent
February 20, 2024
0
Patent Application Number
171398820
Date Filed
December 31, 2020
0
Patent Primary Examiner
‌
Hadi Akhavannik
0
CPC Code
‌
G16H 70/60
0
‌
G16H 10/40
0
‌
G16H 30/40
0
‌
G06N 20/00
0
‌
G01N 33/4833
0
‌
G06T 2207/30204
0
‌
G06T 2207/30024
0
‌
G06T 2207/10056
0
...
Patent abstract

Digital pathology is a promising alternative to manual slide analysis, but improvements in imaging and analysis methods are needed to provide an analysis data set of images that can easily be handled, stored, and importantly, delivered from one data location to another. Methods and software are described herein to improve image collection and analysis.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11908130 Apparatuses and methods for digital pathology

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.